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1. Introduction 
In developed countries in women of reproductive age an increase in obesity levels has been 
widely reported with an associated increase in maternal obesity (Yu et al, 2006, Heslehurst 
et al, 2008, Huda et al, 2010). Obesity in pregnancy is associated with an increased incidence 
of medical complications including gestational diabetes mellitus, pre-eclampsia and venous 
thromboembolism (Huda et al, 2010). As a result, in part, obesity is associated with a higher 
incidence of obstetric interventions such as caesarean section, as well as an increase in 
pregnancy complications including haemorrhage, infection and congenital malformations 
(Yu et al, 2006, Heslehurst, 2008). The World Health Organization criteria define a Body 
Mass Index (BMI) <18.5kg/m2 as underweight, 18.5-24.9 as normal weight, 25.0-29.9 as 
overweight and > 29.9 as obese. Obesity can be further subcategorised into class one obese 
which is 30.0-34.9, class two 35.0-39.9 and class three >40.0. 
2. Rising caesarean section rates 
In 1985, the World Health Organization (WHO) concluded that the caesarean section (CS) 
rate in every region should account for 5-15% of all births (Lancet, 1985). Yet by 2006, the 
CS rate in high-income countries ranged from 14% in the Netherlands to 40% in Italy and 
Mexico (OECD, 2009). In Ireland, the CS rate now exceeds 26% (O’Dwyer and Turner, 
2011).  
The caesarean section rate in the United States (US) has increased further in the last 13 years. 
The CS rate increased from 21% in 1994 to 32% in 2007. When the CS rate was analysed by 
the US Department for Health and Human Sciences, the CS rate was found to increase in all 
ages, racial groups and gestations. This may be due to more conservative clinical practice 
and legal pressures (MacDorman et al, 2008). 
In a 2007 meta-analysis examining strategies to reduce the CS rate, audit and feedback and a 
multifaceted approach were found to reduce the CS rate without compromising maternal 
and fetal outcomes. Multifaceted strategies included the use of clinical guidelines, hospital 
payment policies, malpractice reform and identification of barriers to change. However, 
WHO has since finessed its position on CS rates by stating that the most important issue is 
that every woman who needs a CS should have one. It acknowledges that there is little 
scientific evidence to support a 15% CS rate (Chaillet and Dumont, 2007). 
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3. Rising obesity levels and rising caesarean section rates 
With rising adult obesity levels there has been an associated increase in maternal obesity. A 
Scottish study found that the prevalence of obesity had increased from 9.4% to 18.9% over a 
12 year period (Kanagalingam et al, 2005). In other studies in Britain and Ireland, nearly a 
fifth of women booking for antenatal care were obese (Fattah et al, 2010; CMACE 2010). The 
severity of obesity is also increasing.  Based on the WHO sub-categorisation of obesity, a 
recent UK national audit of pregnant women found that 5.0% had Class 2 or moderate 
obesity and 2.0% had Class 3 or severe obesity (CMACE, 2010).  
Rising levels of obesity in women of child-bearing age and gestational weight gain have 
been reported which has implications for the woman’s lifelong health as well as for the 
pregnancy itself (Sherrard et al, 2007). In the US concerns are so great that the Institute of 
Medicine (IOM) has published new guidelines for weight gain during pregnancy (IOM, 
2009). The new 2009 guidelines are based on the WHO BMI categories with a specific, 
relatively narrow range of recommended gain for obese mothers of 5.0 – 9.0 kgs. 
Numerous studies have reported an association between maternal obesity and an increased 
CS rate (Weiss et al, 2004; Cedergren et al, 2004; Rode et al, 2005). It has been estimated that 
each 1% decrease in the number of obese mothers in the United States would translate into 
16,000 fewer CS per annum.  
There have been three recent meta-analyses which studied the issue of obesity and 
caesarean section. In the 2007 analysis, the risk of CS overall was increased by 2.05 (95% CI 
1.86-2.27) in obese women, and 2.89 (95% CI 2.28-3.79) in morbidly obese women (Chu et al, 
2007).The 2008 meta-analysis found that the overall CS was twice as high in the obese BMI 
category compared with the ideal BMI (MacDorman et al, 2008). The increase was significant 
for emergency sections (n=6 studies), but not for elective sections (n=3 studies). In the 2009 
systematic review and meta-analysis of 11 cohort studies, the risk of CS was increased by 
2.26 (95% CI 2.04-2.51) in obese women and by 3.38 (95% CI 2.49-4.57) in morbidly obese 
women compared with women with a normal BMI (Poobalan et al, 2009). This study was 
confined to primigravidas. There was an increase in both elective (OR 1.87) and emergency 
CS (OR 2.23) in the obese women. 
A 2011 study found that maternal obesity, based on accurate calculation of BMI in the first 
trimester, was associated with an increase in emergency CS in primigravidas and an 
increase in elective CS in multigravidas (O’Dwyer et al, 2011). The increase in emergency CS 
in obese primigravidas was associated with induction of labour and a high rate of CS for 
fetal distress. The increase in elective CS in multigravidas was associated with a high rate of 
repeat elective CS. 
4. Pre-conceptual counselling for obese women 
Pre-pregnancy lifestyle changes including a healthy diet and exercise should be advised. If 
obese women lose weight prior to pregnancy this can prevent some of the pregnancy 
complications associated with obesity including neural tube defects and miscarriage. Obese 
women have a higher risk of neural tube defects (Rasmussen et al, 2008). Therefore it has 
been recommended that they start high dose folic acid supplementation pre-pregnancy 
(CMACE, 2010).  
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It has been reported that maternal obesity is associated with an increased risk of 
spontaneous miscarriage after spontaneous and assisted conception (Metwally et al, 2008). 
Increased rates of miscarriage also occur in obese women with polycystic ovarian syndrome 
(Lashen et al, 2004; Bellver et al, 2003). In a Finish study the miscarriage rate was found to be 
higher at the extremes of weight compared with normal weight women (Veleva et al, 2008). 
In a study examining the probability of pregnancy after assisted reproduction the odds ratio 
was 0.73 for obese Class 1 women and 0.5 for obese Class 2-3 women, compared with 
women in the normal BMI category (Wang et al, 2000; 2002). 
Recurrent miscarriage is defined as three consecutive miscarriages. It affects 1% of couples. 
In a study of 491 women with a history of recurrent miscarriage the miscarriage rates in 
subsequent pregnancies were higher in obese women compared with normal weight women 
(Metwally et al, 2010). In another study the risk of recurrent miscarriage was four times 
higher in obese women compared with normal weight controls. Diabetes mellitus is a 
known cause of recurrent miscarriage but, in this study the prevalence was low in obese 
women and it did not explain their higher risk of miscarriage (Lashen et al, 2004). 
5. Pregnancy after bariatric surgery 
Pregnancy after bariatric surgery is safe once a woman’s weight has stabilised, usually 1 -2 
years after surgery. Antenatal care should include monitoring nutrition and appropriate 
gestational weight gain in these women (Karmon et al, 2008). The risk of maternal and 
neonatal adverse outcomes is lower in women post bariatric surgery than in obese women. 
In a systematic review of pregnancy after bariatric surgery there were lower rates of 
gestational diabetes mellitus, pre-eclampsia, low birth weight babies and macrosomia 
among women after bariatric surgery compared with obese women (Maggard et al, 2008).  
A caesarean section is not required for delivery after bariatric surgery. The risk of 
caesarean section may be lower due to the lower risk of pregnancy complications in 
women after bariatric surgery compared with obese women. However, some studies have 
reported a higher risk of caesarean section in women after bariatric surgery. In a study 
period of 159,210 deliveries, of which 298 deliveries (0.2%) occurred in patients with 
previous bariatric surgery there were higher rates of CS among the bariatric operation 
group (25.2% vs 12.2%; odds ratios, 2.4; 95% confidence interval, 1.9-3.1; p<0.001) (Sheiner 
et al, 2004). 
6. Antenatal care for the obese woman 
Hypertension in pregnancy, including pre-eclampsia, occurs in almost 8% of pregnancies and 
is an important cause of pregnancy complications for both mother and baby.  Pre-eclampsia is 
defined as hypertension (a systolic blood pressure of > 140 mmHg and/or a diastolic blood 
pressure of > 90 mmHg) measured on at least two separate occasions at least 6 hours apart 
with proteinuria (> 300 mg over 24 hours) after 20 weeks gestation. Epidemiological reviews 
have reported an association between pre-eclampsia and maternal obesity, based on a Body 
Mass Index (BMI) > 29.9kg/m2 (Weiss et al, 2004; Abenheim et al, 2007). 
To avoid misdiagnosing pregnancy-induced hypertension or pre-eclampsia women with a 
mid-arm circumference (MAC) >33cm should have their blood pressure measured with a 
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large cuff. Previous studies have reported a MAC >33cm in 44% of class 1 (BMI < 35kg/m2) 
obese women and 100% of class 2-3 (BMI ≥ 35 kg/m2) obese women (Hogan et al, 2010). 
There is a higher rate of caesarean section in women with pre-eclampsia probably due to a 
higher rate of induction of labour (Kim et al, 2010). It is highly desirable that a CS for an 
unsuccessful labour induction is avoided in obese women especially if the induction may 
have been medically unnecessary. Therefore it is important that blood pressure is measured 
accurately in obese women. 
Gestational Diabetes Mellitus (GDM) affects 1.1-14.3% of the pregnant population 
depending on the population studied and on the diagnostic criteria used (SOGC, 2002; 
Reece et al, 2009; Torloni et al, 2009). There is a higher rate of induction of labour and 
caesarean section in women with GDM. Previous studies have reported an association 
between increased rates of Gestational Diabetes Mellitus (GDM) and maternal obesity, 
based on a Body Mass Index (BMI) categorisation > 29.9kg/m2. In a meta-analysis of 20 
studies, the risk of developing GDM was about two, four and eight times higher among 
overweight, obese and severely obese women (Chu et al, 2007). Obese women should be 
offered a glucose tolerance test (GTT) at 24-28 weeks in countries where selective 
screening for GDM is performed (NICE, 2002). By identifying women with gestational 
diabetes the risk of neonatal mortality and morbidity such as congenital abnormalities, 
macrosomia, hypoglycaemia and jaundice may be reduced. There are, however, no 
studies that show that the diagnosis and treatment of GDM in obese women avoids the 
need for CS. Ideally, women should avoid prepregnancy obesity which may prevent the 
development of PET and GDM. 
The HAPO study (2008) found an association between maternal hyperglycaemia and the 
rate of caesarean delivery and separately, gestational diabetes has been shown to be an 
independent risk factor for caesarean delivery (Rosenberg, 2005).  However, others argue 
that obesity is an independent risk factor for caesarean section even when GDM is 
considered a confounder (Sebire et al, 2001; Ehrenberg et al, 2004; Rosenberg, 2005). 
Numerous studies have demonstrated pregestational diabetes to be independent risk 
factor for caesarean delivery (Sebire et al, 2001; Ray et al, 2001; Rosenberg, 2005). The 
complex interaction of obesity, diabetes, insulin resistance and the inflammatory milieu 
during pregnancy is the subject of ongoing research and these factors may have an effect 
on the progression of labour (Hauguel-de Mouzon, 2006; Chu, 2007; Schmatz, 2010). 
Ethnicity is also associated with the rate of caesarean delivery and studies have shown 
higher caesarean section rates in women of African descent (Rosenberg et al, 2005; Bragg 
et al, 2010).  
There is an increased risk of congenital abnormalities, including neural tube defects, cardiac 
abnormalities and gastrointestinal anomalies in obese women compared to those with a 
normal BMI (Rasmussen et al, 2008; Waller et al, 2007). Detection of these anomalies is, 
however, more challenging in obese women (Paldini, 2009).  This is due to poor 
visualisation of fetal anatomy because of the impaired acoustic window. The impaired 
acoustic window is due to the depth of insonation required and the absorption of energy by 
adipose tissue. Structures with low impedance such as the heart, kidneys, lips and 
cerebellum are difficult to visulaise. Despite technical advances such as lower emission 
frequencies, harmonic imaging and speckle reduction ultrasound imaging in obese women 
remains challenging. 
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7. Intrapartum care for the obese woman 
In labour external abdominal fetal heart monitoring is hindered by the amount of 
subcutaneous tissue between the cardiotocograph and the uterus. Fetal scalp electrodes are 
often used instead of external monitoring when continuous fetal surveillance is required. In 
a recent review of intrapartum care for morbidly obese women there was a higher rate of 
invasive fetal monitoring and difficulty monitoring uterine contractions in the morbidly 
obese group compared with normal weight controls. Furthermore, fetal blood sampling can 
be challenging in obese women. Previous studies have described the technical difficulty and 
longer duration required to perform a fetal blood sampling (FBS) in obese women. There 
was also a higher rate of difficulty with vaginal examinations due to poor access to the 
perineum in the morbidly obese women (Ray et al, 2008). 
Ideally morbidly obese women should be reviewed in an anaesthetic clinic as part of their 
antenatal care to access the possibility of peripheral venous access, regional and general 
anaesthesia. The anaesthetist on duty should also be informed when a morbidly obese 
woman presents in established labour. Peripheral venous access should be established early 
in labour. An epidural catheter should be placed early in labour in morbidly obese women 
so that there is no delay if an emergency caesarean section is required.  
Induction of labour is known to be associated with a higher risk of caesarean section than 
spontaneous labour, especially in primigravidas (Seyb et al, 1990). Other studies have 
described a higher rate of failed induction and dystocia in labour for overweight and obese 
women compared with normal weight women (Yu et al, 2006; Vahration et al, 2003). In a 
Liverpool study of labour following induction for prolonged pregnancy the caesarean 
section rate was 38.7% in obese primigravidas compared with 23.8% in normal weight 
primigravidas (Arrowsmith et al, 2011).  
8. Postpartum care 
Obese women are less likely to intend, initiate and continue breastfeeding (Amir and 
Donath, 2007). Thus, obese women may need extra support after caesarean delivery with 
breastfeeding in the hospital and following discharge home (Mok et al, 2008).  
Before discharging an obese woman home it is also a good opportunity for lifestyle advice 
and prepregnancy counselling for the future. A good diet and an exercise programme to 
lose weight postnatally are important.  
Ideally obese women should optimise their weight before conceiving again. They should be 
advised that high dose folic acid is required to minimise the increased risk of neural tube 
defects associated with the low serum folate levels in obese women. Smoking cessation 
should also be advised.  
It is important that obese women with gestational diabetes attend for their 6 week postnatal 
glucose tolerance test to identify those with type 2 diabetes mellitus. However, it is well 
described that attendance for postnatal glucose tolerance testing is poor (Russell et al, 2006; 
Persson et al, 2009). Obese women should be informed that even in the presence of a 
negative postnatal GTT they are at increased risk of type 2 diabetes later in life and that 
weight loss can reduce this risk. 
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9. Technical challenges of caesarean section in obese women 
Ideally obese women should have an anaesthetic consultation before delivery as they are at 
high risk of complications due to obesity and medical co-morbidities. Obese women have 
higher rates of failure of epidural insertion, difficulty with inserting peripheral venous 
access, failed intubation and higher risk of aspiration (Yu et al, 2006). Regional anaesthesia 
in the obese can be technically challenging because of difficulties in identifying the usual 
bony landmarks. Ultrasound has been successfully used in the obese to help identify the 
epidural space and reduce the need for general anaesthesia (Adam & Murphy, 2000). 
Special operating tables are required for morbidly obese women. It may be difficult to 
transfer an obese woman in a manner that is safe for both her and staff, and thus a hoist may 
be necessary. Surgery in the obese parturient can be challenging and requires a number of 
assistants with the increased use of retractors. The placement of the incision should be made 
at a site that will minimise the risk of wound infection. Vertical skin incisions should be 
avoided when possible. In a study of morbidly obese women undergoing primary caesarean 
section those who had a vertical skin incision had a higher rate of wound infection (OR 12.1, 
p<0.001) compared with a transverse skin incision (Wall et al, 2003). 
10. Risks of caesarean section in obese women 
One of the top ten recommendations from the Confidential Enquiries into Maternal and 
Child Health (CEMACH) report launched in 2007 refers to caesarean section. It states that 
whilst recognising that for some mothers and/or their babies’ caesarean section (CS) may be 
the safest mode of delivery, however, mothers must be advised that caesarean section is not 
a risk-free procedure and can cause problems in current and future pregnancies. There are a 
number of complications associated with caesarean section and the risk of these 
complications is increased in obese women. Caesarean section is associated with 
haemorrhage, infection, damage to viscera, anaesthetic complications and long-term 
complications such as placenta accreta. In the 2008 meta-analysis of obstetric outcomes and 
obesity there was an increased risk of wound infection, endometritis and urinary tract 
infection for obese and morbidly obese women compared with those in the normal BMI 
category (Heslehurst et al, 2008). Another risk factor for postcaesarean section infectious 
morbidity is emergency caesarean sections, especially following a trial of labour or 
prolonged rupture of membranes. In a review of 81 clinical trials examining antibiotic 
prophylaxis for women undergoing caesarean section the reduction in endometritis and 
wound infection was significant enough to recommend routine antibiotic prophylaxis for 
these women (Smaill and Hofmeyr, 2002). In a review of 58 controlled trials, the use of 
routine antibiotic prophylaxis was not only found to decrease the risk of wound infection by 
50-70%  but also to decrease the cost of postnatal care  by between £1300 and £3900/100 
caesarean sections (Mugford et al, 1989). There is considerable variation in the timing of 
prophylactic antibiotic administration among surgical patients. In an American study there 
was a lower rate of infection among patients who received prophylactic antibiotics in the 
two hours prior to suregery (Classen et al, 1992). It is now recommended that antibiotic 
prophylaxis is given prior to skin incision. In an American study there was a decrease in 
infectious morbidity women who received cefazolin prior to skin incision compared to those 
who received cefazolin at cord clamping (relative risk [RR] = 0.4, 95% confidence interval 
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[CI] 0.18 to 0.87). In addition to this, studies recommend a higher dose of antibiotic 
prophylaxis for obese women undergoing caesarean section (ACOG, 2011). 
The risk of complications increases with the number of repeat caesarean sections performed. 
(Silver et al, 2006). Bladder and bowel injury can occur at the time of caesarean section. Injury to 
the gastrointestinal tract occurs in 1 in 1300 caesarean deliveries. Increased pain medication 
requirement and longer hospital stay occur following caesarean section compared with vaginal 
delivery. Maternal obesity is also associated with a longer duration of hospital stay (Galtier-
Dereure et al, 2000). Therefore, it is not surprising that maternal obesity has been associated 
with an increase in the use of healthcare resources (Heslehurst, 2008; Rowlands, 2010). 
11. Thromboprophylaxis for obese women undergoing caesarean section 
Pulmonary embolism (PE) is the leading cause of direct maternal death in the UK and the 
developed world (CMACE, 2001; Bourjeily et al, 2010). Maternal obesity has been associated 
with an increased risk of venous thromboembolism (VTE) (Bourjeily et al, 2010). A BMI > 
29.9 kg/m2 in early pregnancy is considered a moderate risk factor for VTE postpartum. An 
elective caesarean section is associated with twice the risk of the VTE risk postpartum when 
compared with a vaginal delivery, and an emergency caesarean section is associated with a 
four-fold increase in risk of VTE (RCOG, 2009). 
There is scant evidence about the optimum administration of low molecular weight 
heparins (LMWH) to women during pregnancy and in the postpartum period (Tooher at al, 
2010). Significant physiological changes occur during pregnancy and may last up to six 
weeks postnatally, thus the efficacy of LMWH doses which are based on studies of the non-
pregnant population are unpredictable. Some evidence, for example, suggests that 
pregnancy affects the pharmacokinetics of tinzaparin (Norris et al, 2004). While the relative 
safety of LMWH use has been established, there is little evidence to guide the appropriate 
prophylactic dose in pregnancy and postpartum. Current guidelines by the Royal College of 
Obstetricians and Gynaecologists (RCOG) indicate suitable doses during pregnancy and the 
postpartum period. Suboptimal thromboprophylaxis in obese women has been described in 
a recent large scale study conducted by CMACE (CMACE, 2010).  
12. Medication dosage in obese patients 
Few studies have examined increased medication costs in obese populations. An Italian 
study detailing medication costs in 2622 patients showed that the obese group required 
more prescriptions annually with a 153% increase in annual medication cost over the normal 
weight group (Esposti et al, 2006). Another study found obesity resulted in a 47% increase in 
pharmacy claims by state employees in Arkansas (Hill et al, 2009).  
There is an even greater dearth of information on obesity in pregnancy and the associated 
medication usage. A study investigating the influence of maternal obesity on healthcare 
costs for minor complications found an increase in the use of sodium alginate, insulin and 
anti-hypertensives (Denison et al (2009). However, the usage of these medications is most 
likely increased in obese patients whether they are pregnant or not. An increase in 
outpatient medication dispensed from community pharmacies has also been reported in 
obese women (Chu et al, 2008). 
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Antenatal medication usage is associated with increasing BMI. This appears to be related to 
the increase in complications during pregnancy with maternal obesity. A large population 
study involving 19,538 pregnancies in the USA describes an association between increased 
outpatient medication usage and increasing BMI (Chu et al, 2008). It also identified an 
increase in the total and postpartum length of hospital stay in women with an increased 
BMI. The effect of increased BMI on length of hospital stay was independent of the mode of 
delivery or the presence of a high-risk obstetric condition (diabetes mellitus, hypertension), 
but was not a significant factor when the authors adjusted for both.  
13. Long-term consequences of caesarean section in obese women 
Trial of labour after caesarean delivery (TOLAC) is a reasonable option for many women 
(Scott, 2011). In the US the increase in the caesarean section rate can be partly attributed to 
the fall in the vaginal birth after caesarean section (VBAC) rate (Mac Dorman et al, 2007). 
The success rate for a planned trial of labour for women with one prior caesarean is 
approximately 75%. It is positively influenced by a history of a vaginal delivery prior to 
caesarean section or a previous VBAC, spontaneous onset of labour, a baby weighing 
between 2.5 and 4kg and not requiring oxytocin augmentation in labour. A BMI ≥ 30 kg/m2 
has a negative influence on the success rate. In a retrospective cohort study of 8,246 
singleton pregnancies in Dublin, the overall caesarean section (CS) rate was 45.3% in women 
with morbid obesity (BMI > 39.9 kg/m2) compared with 14.4% in women with a normal 
BMI (p<0.001). Morbid obesity was associated with an increase in both elective and 
emergency caesarean sections, and a decrease in vaginal birth after caesarean section 
(VBAC) compared with a normal BMI (25.0% vs. 63.5% p<0.001) (Farah et al, 2009).  
There is higher maternal and neonatal morbidity associated with a failed trial of labour 
compared with an elective repeat caesarean section (Landon et al, 2004). The risk of uterine 
rupture is 0.5% for women with one prior lower transverse uterine incision. Certain 
practices can be used to minimise the risk of adverse outcomes in these women including 
uterine rupture. These include the use of colour coded partograms to highlight when a 
woman has a prior caesarean section, avoiding prostaglandin to induce labour and careful 
use of oxytocin to induce or augment labour (Turner, 2002).  
With rising caesarean section rates the incidence of abnormal placentation is increasing. 
Abnormal placentation is a known risk factor for major obstetric haemorrhage and maternal 
morbidity and mortality (Turner et al, 2010).  Thus, the CEMACH report also recommends 
that women who have had a previous caesarean section must have placental localisation in 
their current pregnancy to exclude placenta praevia and if present, further investigation to 
try to identify praevia accreta and enable the development of safe management strategies. 
In a study of 97,799 women, in those who had a prior caesarean section the risk of placenta 
praevia was 0.26% with an unscarred uterus and increased almost linearly with the number of 
prior caesarean sections to 10% in patients with four or more. Patients presenting with a 
placenta praevia and an unscarred uterus had a 5% risk of clinical placenta accreta. With a 
placenta praevia and one previous caesarean section, the risk of placenta accreta was 24% 
(Clark et al, 1985). Another study of 41,206 women found that, in patients with placenta 
praevia the risk of accreta is 8 times greater with scarred uterus compared to unscarred uterus 
with placenta praevia. Furthermore, there was a higher risk of hysterectomy in 10% and 66% 
in women with placenta praevia and accreta and a prior CS (Chattopadhyay et al, 1993). 
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14. Conclusions 
During the twentieth century there were remarkable advances in obstetric practices which 
led to great improvements in clinical outcomes for women and their offspring, particularly 
in well-resourced countries. However, overabundance of food and changes in physical 
activity levels in these countries have also led to rising levels of maternal obesity which risk 
reversing the improvements achieved in maternal and fetal outcomes. Caesarean delivery in 
the morbidly obese woman is both clinically and technically challenging. Ideally, morbid 
obesity is a modifiable risk factor that should be modified prepregnancy. If morbid obesity 
is present in early pregnancy, a comprehensive multidisciplinary plan is mandated to 
prevent complications and minimise interventions. 
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